Cigna (CI) Cash & Equivalents (2017 - 2026)

Cigna's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $7.0 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 15.53% year-over-year to $7.0 billion; the TTM figure through Mar 2026 stood at $7.0 billion (down 15.53% YoY), while the FY2025 annual figure was $7.7 billion, up 1.67% from the prior year.
• Cash & Equivalents came in at $7.0 billion for Q1 2026 at Cigna, down from $7.7 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $9.6 billion in Q2 2023 to a low of $4.3 billion in Q2 2025.
• A 5-year average of $6.9 billion and a median of $7.1 billion in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 116.81% in 2023 and sank 36.23% in 2025, its largest moves.
• Cigna's Cash & Equivalents stood at $5.9 billion in 2022, then soared by 32.04% to $7.8 billion in 2023, then declined by 3.48% to $7.6 billion in 2024, then increased by 1.67% to $7.7 billion in 2025, then slipped by 8.29% to $7.0 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $7.0 billion, $7.7 billion, and $6.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison